{"page_content": "2020 CORPORATE SOCIAL RESPONSIBILITY REPORT34\nDear Communities\nABOUT SERVE TRANSFORM ADVANCE REDEFINE ETHICS & COMPLIANCE REPORTING INDEX   \nIn 2020, as part of our continued commitment to report on our clinical study data, \nas well as generate real-world evidence to document the benefits and safety of our \nmedicines, Alexion reports the following progress: COMMUNICATING SAFETY AND EFFICACY  \nJustice, living with aHUSTHE PATIENT   \nGUIDES PROJECT  \nIn 2020, Alexion collaborated with Deutsche \nGesellschaft f\u00fcr Muskelkranke (DGM), a leading \npatient organization in Germany that serves people \nliving with a variety of neuromuscular diseases. \nThe Patient Guides Project is aimed at improving \ncommunication and support for patients and \ncaregivers at neuromuscular disease certified \ntreatment centers as they work to navigate the  \noften-fragmented treatment landscape.37 congresses joined with participation\n33 oral presentations given65manuscripts submitted;  \n40 published (by the end of 2020)173abstracts submitted;  \n92% accepted\n117 posters developed17medical symposia delivered;  \n10,000+ medical symposia attendees reached  4plain-language summaries of manuscripts prepared  \n(one published; three under journal review) \n15 plain-language summaries published/presented ", "metadata": {"source": "NASDAQ_ALXN_2020.pdf", "page": 33, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}